FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Lea Madi

Research Profile

Chemicals & Drugs

Living Beings

Physiology

Anatomy

Tumor Cells, Cultured

Disorders

Procedures

Administration, Oral

Phenomena

Blotting, Western

Co-author Network

Publications

TOP 3
Sara Bar-Yehuda; S M Stemmer; Lea Madi; D Castel; Avivit Ochaion; Shira Cohen; Faina Barer; A Zabutti; G Perez-Liz; Luis Del Valle; Pnina Fishman
The A3 adenosine receptor agonist CF102 induces apoptosis of hepatocellular carcinoma via de-regulation of the Wnt and NF-kappaB signal transduction pathways.
Lea Madi; Shira Cohen; Avivit Ochayin; Sara Bar-Yehuda; Faina Barer; Pnina Fishman
Overexpression of A3 adenosine receptor in peripheral blood mononuclear cells in rheumatoid arthritis: involvement of nuclear factor-kappaB in mediating receptor level.
Lea Rath-Wolfson; Sara Bar-Yehuda; Lea Madi; Avivit Ochaion; Shira Cohen; A Zabutti; Pnina Fishman
IB-MECA, an A3 adenosine receptor agonist prevents bone resorption in rats with adjuvant induced arthritis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Lea Madi (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: Sara Bar-Yehuda; S M Stemmer; Lea Madi; D Castel; Avivit Ochaion; Shira Cohen; Faina Barer; A Zabutti; G Perez-Liz; Luis Del Valle; Pnina Fishman
The A3 adenosine receptor agonist CF102 induces apoptosis of hepatocellular carcinoma via de-regulation of the Wnt and NF-kappaB signal transduction pathways.
International journal of oncology 2008;33(2):287-95.
2007: Lea Madi; Shira Cohen; Avivit Ochayin; Sara Bar-Yehuda; Faina Barer; Pnina Fishman
Overexpression of A3 adenosine receptor in peripheral blood mononuclear cells in rheumatoid arthritis: involvement of nuclear factor-kappaB in mediating receptor level.
The Journal of rheumatology 2007;34(1):20-6.
2006: Lea Rath-Wolfson; Sara Bar-Yehuda; Lea Madi; Avivit Ochaion; Shira Cohen; A Zabutti; Pnina Fishman
IB-MECA, an A3 adenosine receptor agonist prevents bone resorption in rats with adjuvant induced arthritis.
Clinical and experimental rheumatology 2006;24(4):400-6.
2006: Avivit Ochaion; Sara Bar-Yehuda; Shira Cohn; Luis Del Valle; Georginia Perez-Liz; Lea Madi; Faina Barer; Motti Farbstein; Sari Fishman-Furman; Tatiana Reitblat; Alexander Reitblat; Howard Amital; Yair Levi; Yair Molad; Reuven Mader; Moshe Tishler; Pnina Langevitz; Alexander Zabutti; Pnina Fishman
Methotrexate enhances the anti-inflammatory effect of CF101 via up-regulation of the A3 adenosine receptor expression.
Arthritis research & therapy 2006;8(6):R169.
2006: Pnina Fishman; Sara Bar-Yehuda; Lea Madi; Lea Rath-Wolfson; Avivit Ochaion; Shira Cohen; Ehud Baharav
The PI3K-NF-kappaB signal transduction pathway is involved in mediating the anti-inflammatory effect of IB-MECA in adjuvant-induced arthritis.
Arthritis research & therapy 2006;8(1):R33.
2005: Ehud Baharav; Sara Bar-Yehuda; Lea Madi; Daniel Silberman; Lea Rath-Wolfson; Marisa Halpren; Avivit Ochaion; Abraham Weinberger; Pnina Fishman
Antiinflammatory effect of A3 adenosine receptor agonists in murine autoimmune arthritis models.
The Journal of rheumatology 2005;32(3):469-76.
2005: Sara Bar-Yehuda; Lea Madi; Daniel Silberman; Slosman Gery; Maya Shkapenuk; Pnina Fishman
CF101, an agonist to the A3 adenosine receptor, enhances the chemotherapeutic effect of 5-fluorouracil in a colon carcinoma murine model.
Neoplasia (New York, N.Y.) 2005;7(1):85-90.
2004: Lea Madi; Avivit Ochaion; Lea Rath-Wolfson; Sara Bar-Yehuda; Abigail Erlanger; Gil Ohana; Arie Harish; Ofer Merimski; Faina Barer; Pnina Fishman
The A3 adenosine receptor is highly expressed in tumor versus normal cells: potential target for tumor growth inhibition.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(13):4472-9.
2004: Pnina Fishman; Sara Bar-Yehuda; Gil Ohana; Faina Barer; Avivit Ochaion; Abigail Erlanger; Lea Madi
An agonist to the A3 adenosine receptor inhibits colon carcinoma growth in mice via modulation of GSK-3 beta and NF-kappa B.
Oncogene 2004;23(14):2465-71.
2003: Lea Madi; Sara Bar-Yehuda; Faina Barer; Eti Ardon; Avivit Ochaion; Pnina Fishman
A3 adenosine receptor activation in melanoma cells: association between receptor fate and tumor growth inhibition.
The Journal of biological chemistry 2003;278(43):42121-30.
2003: Gil Ohana; Sara Bar-Yehuda; A Arich; Lea Madi; Z Dreznick; Lea Rath-Wolfson; Daniel Silberman; G Slosman; Pnina Fishman
Inhibition of primary colon carcinoma growth and liver metastasis by the A3 adenosine receptor agonist CF101.
British journal of cancer 2003;89(8):1552-8.
2003: Pnina Fishman; Sara Bar-Yehuda; Eti Ardon; Lea Rath-Wolfson; Faina Barrer; Avivit Ochaion; Lea Madi
Targeting the A3 adenosine receptor for cancer therapy: inhibition of prostate carcinoma cell growth by A3AR agonist.
Anticancer research 2003;23(3A):2077-83.
2002: Sara Bar-Yehuda; Lea Madi; Dana Barak; Moshe Mittelman; Eti Ardon; Avivit Ochaion; Shira Cohn; Pnina Fishman
Agonists to the A3 adenosine receptor induce G-CSF production via NF-kappaB activation: a new class of myeloprotective agents.
Experimental hematology 2002;30(12):1390-8.
2002: Pnina Fishman; Lea Madi; Sara Bar-Yehuda; Faina Barer; Luis Del Valle; Kamel Khalili
Evidence for involvement of Wnt signaling pathway in IB-MECA mediated suppression of melanoma cells.
Oncogene 2002;21(25):4060-4.
2002: Pnina Fishman; Sara Bar-Yehuda; Lea Madi; Ilan Cohn
A3 adenosine receptor as a target for cancer therapy.
Anti-cancer drugs 2002;13(5):437-43.
2001: Pnina Fishman; Sara Bar-Yehuda; Faina Barer; Lea Madi; A S Multani; S Pathak
The A3 adenosine receptor as a new target for cancer therapy and chemoprotection.
Experimental cell research 2001;269(2):230-6.